“The clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife-LC) in the treatment of decompensated hepatitis B liver cancer” will initiate a third diagnosis and treatment method for digestive diseases (severe hepatitis, chronic hepatitis, hepatocirrhosis, liver failure, etc.) with  special effects